2014 annual financial data
Anika Therapeutics 2014 Net margin
Direct answer
Net margin was 36.29%.
Operating income was 61,446,884 USD and net income was 38,319,479 USD.
Operating cash flow was 39,978,375 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 105,594,839 USD
- Operating income
- 61,446,884 USD
- Net income
- 38,319,479 USD
- Operating cash flow
- 39,978,375 USD